top of page
About Us
Meaning of "Heka"
Egyptian god of
Magic and Medicine
HekaBio is an asset-light emerging commercial-stage biopharma and MedTech operating company that in-licenses early, de-risked assets to commercialize in Japan and the APAC region.
​
We conduct clinical trials, secure regulatory and pricing approvals and optimize commercial opportunities within two to four years through our strong network of partners in pharma,
MedTech, and hospitals.
​
Our multicultural team has 50+ approvals in Japan and a stellar
in-licensed portfolio at an inflection point for commercial sales beginning in H1 2026.
Our Mission
Accelerating patient access to world-leading healthcare solutions throughout the APAC region, starting with Japan
Our Core Values
bottom of page